Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC40A1 | Q9NP59 | 9/20 | 0.48 |
| ▸ | GLO1 | Q04760 | 3/20 | 0.48 |
| ▸ | NAMPT | P43490 | 2/20 | 0.42 |
| ▸ | CKS1B | P61024 | 5/20 | 0.41 |
| ▸ | SKP2 | Q13309 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MITF | O75030 | 1/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30846443 | 1.00 | SLC40A1 (0.48) | SLC40A1GLO1NAMPTCKS1BSKP2 | |
| SCHEMBL30846465 | 0.91 | SLC40A1 (0.40) | SLC40A1GLO1NAMPTCKS1BSKP2 | |
| SCHEMBL27118193 | 0.91 | SLC40A1 (0.40) | SLC40A1GLO1NAMPTCKS1BSKP2 | |
| SCHEMBL27118078 | 0.91 | SLC40A1 (0.42) | SLC40A1GLO1NAMPTCKS1BSKP2 | |
| SCHEMBL30846306 | 0.91 | SLC40A1 (0.42) | SLC40A1GLO1NAMPTCKS1BSKP2 | |
| SCHEMBL27118142 | 0.88 | SLC40A1 (0.41) | SLC40A1GLO1CKS1BSKP2KMT2A | |
| SCHEMBL30846341 | 0.88 | SLC40A1 (0.41) | SLC40A1GLO1CKS1BSKP2KMT2A | |
| SCHEMBL30846415 | 0.87 | SLC40A1 (0.46) | SLC40A1GLO1CKS1BSKP2KMT2A | |
| SCHEMBL30846413 | 0.87 | SLC40A1 (0.46) | SLC40A1GLO1CKS1BSKP2KMT2A | |
| SCHEMBL27118191 | 0.87 | SLC40A1 (0.46) | SLC40A1GLO1CKS1BSKP2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240150365-A1 | PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS, INC. | 2024-05-09 | — | — | US | disclosed |
| WO-2024044344-A1 | PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS, INC. (US) | 2024-02-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150365-A1 | PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | MALT1, BCL6, BCL6B | SLC40A1 816/4885GLO1 3644/4885NAMPT 552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.